SCHEMBL13080697

SCHEMBL13080697

CC(C)C[C@@H](O)C(=O)N1CCN(c2nc(-c3ccccc3)nc3ccc(C#N)cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
TSHR P16473 2/20 0.49
GBA1 P04062 4/20 0.47
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
SMO Q99835 1/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
HIF1A Q16665 1/20 0.42
RCE1 Q9Y256 1/20 0.42
STAT6 P42226 1/20 0.42
PIK3CA P42336 1/20 0.42
ACP1 P24666 2/20 0.41
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1623805 0.90 MEN1 (0.46) CYP1A2CYP3A4CYP2D6TSHRGBA1
SCHEMBL1623803 0.90 MEN1 (0.46) CYP1A2CYP3A4CYP2D6TSHRGBA1
Hydrochloric Acid SCHEMBL1623435 0.89 MEN1 (0.46) CYP1A2CYP3A4CYP2D6TSHRGBA1
Hydrochloric Acid SCHEMBL1623437 0.89 MEN1 (0.46) CYP1A2CYP3A4CYP2D6TSHRGBA1
SCHEMBL13080698 0.86 MEN1 (0.46) TSHRGBA1LMNAKDM4ENPSR1
SCHEMBL13080669 0.86 ACP1 (0.57) CYP1A2TSHRGBA1LMNATP53
SCHEMBL13080736 0.86 ACP1 (0.57) CYP1A2TSHRGBA1LMNATP53
SCHEMBL13080682 0.83 ACP1 (0.46) CYP1A2TSHRGBA1LMNATP53
SCHEMBL13080699 0.83 GBA1 (0.47) TSHRGBA1LMNATP53KDM4E
SCHEMBL13080784 0.83 GBA1 (0.47) TSHRGBA1LMNATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 US disclosed